Asper Biogene – genetic testing company

It is a new and exciting year full of great progress for Asper Biotech and we do all that for you dear customers and partners. Sometimes tiny details around the activities may remain unnoticed from you despite they might matter for you, therefore we decided to open up a Twitter account[at]asperbiotech. We will use this channel to share  you news about Asper Biotech, as well as stories and scientific breakthroughs that our team has picked up from media. We would appreciate if you could add our Twitter account[at]asperbiotech to your list of followed sources and share this news further to your friends and colleagues. We would like to be in touch with your achievements,  so we will do our best to follow you as well.

Asper Biotech is pleased to introduce a new addition to our lab – MiSeq sequencer from Illumina. Part of our strategy lies in broadening the variety of different technologies used in DNA testing. Once the initial training has been completed and the MiSeq has been adapted for our lab environment and everyday working processes we will provide more information about our next generation sequencing services currently under development.

Asper Biotech proudly announces that we received CLIA Certificate (ID 99D2046227), proving our laboratory services being in compliance with all applicable CLIA requirements. We have been steadily operating in accordance with the highest clinical standards and good laboratory practice. Hence, becoming a CLIA approved laboratory affirms our common effort to systematically improve the quality of our diagnostic services.